Mass Spectrometry Applications for Clinical Research
MSACL EU 2015
LC-MS/MS offers many technical and financial advantages for the clinical research laboratory and is now seen as a complementary, or in some cases, viable alternative to immunoassays.
This seminar will bring together scientists, clinicians and biochemists that hold an interest in the use of Mass Spectrometry in the areas of Clinical Research as we discuss what can be achieved with today’s technology and what we can expect in the future.
Topic: The use of advanced accurate mass MS technologies in ovarian cancer biomarker research
Dr. Robert Graham Senior Lecturer, Clinical Proteomics Academic lead for biomarker analysis within PROMISE (Predicting Risk of Ovarian Malignancies, Improved Screening and Early Detection University of Manchester, UK
Topic: Novel and advanced MS technologies specifically with respect to their use in reducing background and matrix effects in sample analysis.
Dr Michael Wright Senior Leader in Clinical Chemistry and Endocrinology Prince of Wales Hospital Sydney